ECSP067028A - Profármacos de esteroides con acción androgénica - Google Patents

Profármacos de esteroides con acción androgénica

Info

Publication number
ECSP067028A
ECSP067028A EC2006007028A ECSP067028A ECSP067028A EC SP067028 A ECSP067028 A EC SP067028A EC 2006007028 A EC2006007028 A EC 2006007028A EC SP067028 A ECSP067028 A EC SP067028A EC SP067028 A ECSP067028 A EC SP067028A
Authority
EC
Ecuador
Prior art keywords
steroid
propharms
androgenic action
androgenic
action
Prior art date
Application number
EC2006007028A
Other languages
English (en)
Spanish (es)
Inventor
Alexander Hillisch
Ralf Wyrwa
Sven Ring
Walter Elger
Birgitt Schneider
Peter Droescher
Gudrun Reddersen
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ECSP067028A publication Critical patent/ECSP067028A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EC2006007028A 2004-05-21 2006-11-27 Profármacos de esteroides con acción androgénica ECSP067028A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung

Publications (1)

Publication Number Publication Date
ECSP067028A true ECSP067028A (es) 2006-12-29

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006007028A ECSP067028A (es) 2004-05-21 2006-11-27 Profármacos de esteroides con acción androgénica

Country Status (22)

Country Link
EP (1) EP1747229A1 (zh)
JP (1) JP2007538026A (zh)
CN (1) CN1993375A (zh)
AR (1) AR049547A1 (zh)
AU (1) AU2005245568A1 (zh)
BR (1) BRPI0510136A (zh)
CA (1) CA2564963A1 (zh)
CR (1) CR8785A (zh)
DE (1) DE102004025986A1 (zh)
EA (1) EA200602049A1 (zh)
EC (1) ECSP067028A (zh)
GT (1) GT200500122A (zh)
IL (1) IL179293A0 (zh)
MX (1) MXPA06013469A (zh)
NO (1) NO20065885L (zh)
PA (1) PA8633601A1 (zh)
PE (1) PE20060271A1 (zh)
SV (1) SV2006002123A (zh)
TW (1) TW200613317A (zh)
UY (1) UY28911A1 (zh)
WO (1) WO2005113575A1 (zh)
ZA (1) ZA200610769B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
GT200500122A (es) 2006-01-24
CA2564963A1 (en) 2005-12-01
IL179293A0 (en) 2007-03-08
AR049547A1 (es) 2006-08-16
CN1993375A (zh) 2007-07-04
CR8785A (es) 2007-02-05
BRPI0510136A (pt) 2007-10-02
UY28911A1 (es) 2005-12-30
EP1747229A1 (de) 2007-01-31
TW200613317A (en) 2006-05-01
PA8633601A1 (es) 2006-07-03
WO2005113575A1 (de) 2005-12-01
JP2007538026A (ja) 2007-12-27
DE102004025986A1 (de) 2005-12-15
PE20060271A1 (es) 2006-05-25
MXPA06013469A (es) 2007-01-23
EA200602049A1 (ru) 2007-06-29
AU2005245568A1 (en) 2005-12-01
ZA200610769B (en) 2008-08-27
NO20065885L (no) 2006-12-19
SV2006002123A (es) 2006-02-15

Similar Documents

Publication Publication Date Title
UY32648A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de enfermedades
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
ECSP067028A (es) Profármacos de esteroides con acción androgénica
UY31524A1 (es) Nuevos compuestos 010
ECSP099452A (es) Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
CO6351783A2 (es) Derivados de indazoles sustituidos con fenilo o piridinilo
ECSP11011390A (es) Compuestos espiro-amidas sustituidas
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
ECSP099620A (es) Derivados de ciclohexano espirociclico
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
ECSP099425A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenorecetor beta 2
AR116001A2 (es) Composición farmacéutica 271
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
ECSP10010200A (es) Derivados de pirazol como inhibidores de 5-lo
TW200613315A (en) Estradiol prodrugs
CR9595A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona
UY31338A1 (es) Compuestos novedosos activos como antagonistas de receptores muscarinicos
ECSP088482A (es) Prodrogas de sustancias er-beta-selectivas, procesos para su preparación, y composiciones farmacéuticas que contienen estos compuestos
ECSP066973A (es) D-homo-17-cloro-16(17)eno esteroides
CU23875B1 (es) Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
UY28846A1 (es) D-homo-17-cloro-16 (17) eno esteroides
BRPI0604318A (pt) esteróides d-homo-17-clor-16(17)-eno